Search results for “α4β7 integrin” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 166 patents, we discovered top 19 key players by total patent application. Millennium Pharmaceuticals, Inc., Genentech, Inc., Morphic Therapeutic, Inc. are dominant in this area. They take 51.20% of the total patent filing.
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 55
Genentech, Inc.
California, United States
Patent: 15
STARTUP
Morphic Therapeutic, Inc.
Massachusetts, United States
Patent: 15
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 12
Protagonist Therapeutics, Inc.
Queensland, Australia
Patent: 11
ChemoCentryx, Inc.
California, United States
Patent: 9
Prometheus Biosciences, Inc
California, United States
Patent: 8
Gilead Sciences, Inc.
California, United States
Patent: 7
Zealand Pharma A/S
Hovedstaden, Denmark
Patent: 7
Nestec SA
Vaud, Switzerland
Patent: 7
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 15 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Morphic Therapeutic, Inc.
Massachusetts, United States
Patent: 15
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 63 patents applied in the last 5 years. We discover 15 most active companies in this area. The fast-growing Morphic Therapeutic, Inc., Millennium Pharmaceuticals, Inc., Gilead Sciences, Inc. take 49.21% of patent filing during this period.
STARTUP
Morphic Therapeutic, Inc.
Massachusetts, United States
Patent: 15
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 9
Gilead Sciences, Inc.
California, United States
Patent: 7
Protagonist Therapeutics, Inc.
Queensland, Australia
Patent: 5
Prometheus Biosciences, Inc
California, United States
Patent: 5
ChemoCentryx, Inc.
California, United States
Patent: 5
Zealand Pharma A/S
Hovedstaden, Denmark
Patent: 5
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 3
Encycle Therapeutics, Inc.
Ontario, Canada
Patent: 3
Nestec SA
Vaud, Switzerland
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 63 patents in last 5 years, we discover 6 new entrants. Morphic Therapeutic, Inc., Gilead Sciences, Inc., Polpharma Biologics S.A. are the most active new entrants in this area.
STARTUP
Morphic Therapeutic, Inc.
Massachusetts, United States
Patent: 15
Gilead Sciences, Inc.
California, United States
Patent: 7
Polpharma Biologics S.A.
Pomorskie, Poland
Patent: 1
Academisch Ziekenhuis Maastricht
Netherlands
Patent: 1
Guangzhou Zhaoxue Technology Co., Ltd.
Guangdong Sheng, China
Patent: 1
University of Groningen
Groningen, Netherlands
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 7 patents, we discovered top 1 universities and scientific research institutions by total patent application.
University of Groningen
Groningen, Netherlands
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: